Skip to main content
Premium Trial:

Request an Annual Quote

NIH to Fund Coordination Center for Alzheimer's Research

NEW YORK (GenomeWeb) - The National Institutes of Health plans to fund a coordination center to facilitate the replication phase of the Alzheimer's Disease Sequencing Project.

Supported by the National Institute on Aging, the funds will go toward establishing the NIA Coordinating Center for the Genetics and Genomics of Alzheimer's Disease.

The ultimate aim of the ADSP is to identify the genomic contributions to both risks for Alzheimer's and protection against the disease, as well as the correlation between human genetic variation and the relationship to health and disease. The discovery phase generated several data sets from whole-genome and whole-exome sequencing studies. The replication phase will examine a subset of genes, regions, and loci implicated during the discovery phase.

During the replication phase, findings of the discovery phase and other research groups will be confirmed and data will be aggregated, harmonized, and analyzed to identify and validate risk and protective alleles for Alzheimer's. Activities the center could facilitate and support include genome-wide association studies, genotyping by custom chip, targeted sequencing, data tracking, quality control checks, and other analyses.

To fund the center, NIA plans to commit $2.25 million in Fiscal Year 2016 comprising one new grant, with up to $2 million per year in direct costs for the duration of the project up to five years.

Applications will be accepted from May 3, 2015 until June 3, 2015.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.